vs
Side-by-side financial comparison of Apollo Commercial Real Estate Finance, Inc. (ARI) and Inogen Inc (INGN). Click either name above to swap in a different company.
Apollo Commercial Real Estate Finance, Inc. is the larger business by last-quarter revenue ($73.3M vs $68.6M, roughly 1.1× Inogen Inc). On growth, Apollo Commercial Real Estate Finance, Inc. posted the faster year-over-year revenue change (4.0% vs 3.4%). Over the past eight quarters, Inogen Inc's revenue compounded faster (4.2% CAGR vs -4.6%).
Apollo Commercial Real Estate Finance, Inc. is a real estate investment trust that originates, acquires and manages commercial real estate debt assets including mortgages, mezzanine loans and mortgage-backed securities, primarily operating in the U.S. market to deliver consistent risk-adjusted returns.
Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.
ARI vs INGN — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $73.3M | $68.6M |
| Net Profit | $29.2M | — |
| Gross Margin | — | 51.4% |
| Operating Margin | 39.7% | -13.6% |
| Net Margin | 39.9% | — |
| Revenue YoY | 4.0% | 3.4% |
| Net Profit YoY | -28.2% | — |
| EPS (diluted) | $0.19 | $-0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $73.3M | $68.6M | ||
| Q3 25 | $61.6M | $79.1M | ||
| Q2 25 | $70.9M | $79.2M | ||
| Q1 25 | $65.8M | $68.5M | ||
| Q4 24 | $70.5M | $66.3M | ||
| Q3 24 | $71.6M | $74.9M | ||
| Q2 24 | $81.1M | $74.4M | ||
| Q1 24 | $80.5M | $63.1M |
| Q4 25 | $29.2M | — | ||
| Q3 25 | $50.8M | $-5.3M | ||
| Q2 25 | $20.7M | $-4.2M | ||
| Q1 25 | $26.0M | $-6.2M | ||
| Q4 24 | $40.7M | — | ||
| Q3 24 | $-91.5M | $-6.0M | ||
| Q2 24 | $35.8M | $-5.6M | ||
| Q1 24 | $-104.5M | $-14.6M |
| Q4 25 | — | 51.4% | ||
| Q3 25 | — | 52.2% | ||
| Q2 25 | — | 52.2% | ||
| Q1 25 | — | 53.1% | ||
| Q4 24 | — | 54.7% | ||
| Q3 24 | — | 55.2% | ||
| Q2 24 | — | 57.4% | ||
| Q1 24 | — | 54.5% |
| Q4 25 | 39.7% | -13.6% | ||
| Q3 25 | 82.8% | -9.0% | ||
| Q2 25 | 29.4% | -7.7% | ||
| Q1 25 | 39.7% | -11.2% | ||
| Q4 24 | 57.9% | -17.2% | ||
| Q3 24 | -127.8% | -10.4% | ||
| Q2 24 | 44.2% | -9.5% | ||
| Q1 24 | -129.6% | -25.8% |
| Q4 25 | 39.9% | — | ||
| Q3 25 | 82.4% | -6.7% | ||
| Q2 25 | 29.3% | -5.2% | ||
| Q1 25 | 39.5% | -9.0% | ||
| Q4 24 | 57.7% | — | ||
| Q3 24 | -127.9% | -8.0% | ||
| Q2 24 | 44.1% | -7.5% | ||
| Q1 24 | -129.8% | -23.1% |
| Q4 25 | $0.19 | $-0.26 | ||
| Q3 25 | $0.34 | $-0.20 | ||
| Q2 25 | $0.12 | $-0.15 | ||
| Q1 25 | $0.16 | $-0.25 | ||
| Q4 24 | $0.25 | $-0.41 | ||
| Q3 24 | $-0.69 | $-0.25 | ||
| Q2 24 | $0.23 | $-0.24 | ||
| Q1 24 | $-0.76 | $-0.62 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $139.8M | $103.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.9B | $192.2M |
| Total Assets | $9.9B | $298.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $139.8M | $103.7M | ||
| Q3 25 | $245.9M | $106.5M | ||
| Q2 25 | $177.6M | $103.7M | ||
| Q1 25 | $166.4M | $118.9M | ||
| Q4 24 | $317.4M | $113.8M | ||
| Q3 24 | $194.3M | $105.7M | ||
| Q2 24 | $174.7M | $97.9M | ||
| Q1 24 | $161.2M | $107.4M |
| Q4 25 | $1.9B | $192.2M | ||
| Q3 25 | $1.9B | $197.2M | ||
| Q2 25 | $1.8B | $199.5M | ||
| Q1 25 | $1.9B | $198.0M | ||
| Q4 24 | $1.9B | $173.9M | ||
| Q3 24 | $1.9B | $185.4M | ||
| Q2 24 | $2.0B | $187.6M | ||
| Q1 24 | $2.0B | $191.9M |
| Q4 25 | $9.9B | $298.6M | ||
| Q3 25 | $9.5B | $307.0M | ||
| Q2 25 | $9.8B | $312.0M | ||
| Q1 25 | $8.8B | $308.4M | ||
| Q4 24 | $8.4B | $296.2M | ||
| Q3 24 | $9.1B | $306.2M | ||
| Q2 24 | $9.3B | $308.9M | ||
| Q1 24 | $9.2B | $315.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $142.5M | $-943.0K |
| Free Cash FlowOCF − Capex | — | $-1.9M |
| FCF MarginFCF / Revenue | — | -2.8% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | 4.88× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-13.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $142.5M | $-943.0K | ||
| Q3 25 | $31.7M | $2.2M | ||
| Q2 25 | $63.2M | $4.3M | ||
| Q1 25 | $39.3M | $-16.8M | ||
| Q4 24 | $200.3M | $-3.0M | ||
| Q3 24 | $47.2M | $7.0M | ||
| Q2 24 | $50.2M | $6.7M | ||
| Q1 24 | $52.8M | $-4.7M |
| Q4 25 | — | $-1.9M | ||
| Q3 25 | — | $1.6M | ||
| Q2 25 | — | $3.7M | ||
| Q1 25 | — | $-17.1M | ||
| Q4 24 | — | $-3.3M | ||
| Q3 24 | — | $5.3M | ||
| Q2 24 | — | $6.6M | ||
| Q1 24 | — | $-6.1M |
| Q4 25 | — | -2.8% | ||
| Q3 25 | — | 2.0% | ||
| Q2 25 | — | 4.6% | ||
| Q1 25 | — | -24.9% | ||
| Q4 24 | — | -5.0% | ||
| Q3 24 | — | 7.1% | ||
| Q2 24 | — | 8.9% | ||
| Q1 24 | — | -9.6% |
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 0.7% | ||
| Q2 25 | — | 0.9% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 0.5% | ||
| Q3 24 | — | 2.2% | ||
| Q2 24 | — | 0.1% | ||
| Q1 24 | — | 2.1% |
| Q4 25 | 4.88× | — | ||
| Q3 25 | 0.62× | — | ||
| Q2 25 | 3.05× | — | ||
| Q1 25 | 1.51× | — | ||
| Q4 24 | 4.93× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 1.40× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ARI
Segment breakdown not available.
INGN
| Other | $36.1M | 53% |
| Non Us | $32.5M | 47% |
